HKSE · 3613.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:29 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Beijing Tong Ren Tang Chinese Medicine Company Limited’s quoted price sits in the lower half of its reported 52-week range, 40.58% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Beijing Tong Ren Tang Chinese Medicine Company Limited’s forward annual dividend is HK$0.33 per share, paid annual. The forward yield is 5.85% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Beijing Tong Ren Tang Chinese Medicine Company Limited’s next earnings report is currently expected on Apr 1, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Beijing Tong Ren Tang Chinese Medicine Company Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Beijing Tong Ren Tang Chinese Medicine Company Limited, encompassing its various affiliates, specializes in the production, distribution, and direct sale of traditional Chinese medicine and wellness items, catering to both corporate distributors and individual consumers. Its operations are geographically segmented across Hong Kong, Mainland China, and international markets. Additionally, the company provides traditional Chinese medical consultations and therapeutic services. The firm maintains a network of 23 retail stores throughout Hong Kong, complemented by 46 international outlets located across Asia, Oceania, North America, and Europe. All its offerings are sold under the well-recognized Tong Ren Tang brand. Established in 1669, the company's main office is situated in Wan Chai, Hong Kong.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:57 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Aug 10, 2023 |
| HK$0.32 |
| HK$812.81M |
| Q4 2022 | Mar 13, 2023 | HK$0.26-71.74% vs estimate | HK$1.11B-45.74% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$1.18+HK$0.03 (+2.62%)
China Traditional Chinese Medicine Holdings Co. Limited’s quoted price sits in the lower half of its reported 52-week range, 51.04% below the high.
HK$2.98+HK$0.07 (+2.41%)
Tong Ren Tang Technologies Co. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.8% below the high.
HK$2.65-HK$0.05 (-1.85%)
Jilin Province Huinan Changlong Bio-pharmacy Company Limited’s quoted price sits in the upper half of its reported 52-week range, 11.67% below the high.
HK$1.41-HK$0.03 (-2.08%)
Beijing Tong Ren Tang Healthcare Investment Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 70.56% below the high.
HK$0.63-HK$0.02 (-2.34%)
Zhongzhi Pharmaceutical Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 36.22% below the high.
HK$0.36+HK$0.02 (+5.88%)
Wai Yuen Tong Medicine Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 26.53% below the high.
HK$0.34HK$0.00 (0.0%)
Modern Chinese Medicine Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 89.57% below the high.
HK$0.09HK$0.00 (0.0%)
Tianda Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 35.97% below the high.
